InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,267.84
(
-0.74%
)
US TECH 100
18,152.00
(
-0.42%
)
Dow Jones
39,065.26
(
-1.53%
)
Brent Oil
81.18
(
-0.17%
)
Bitcoin
67,897.10
(
-0.04%
)
Post# of 251927
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 829
Posts 119686
Boards Moderated 16
Alias Born 09/05/2002

DewDiligence

Member Level

Re: bladerunner1717 post# 233823

Thursday, 07/23/2020 4:50:21 PM

Thursday, July 23, 2020 4:50:21 PM

Post# of 251927
MRNA/ABUS—From the same source:

Moderna (MRNA) challenged patents held by Arbutus Biopharma (ABUS) covering lipid nanoparticle technology.

…In a hearing Thursday, Moderna unsuccessfully argued Arbutus' claims shouldn't be patented, SVB Leerink analyst Mani Foroohar said in a report. He called the decision in Arbutus' favor "a disappointing turn for Moderna." Moderna stock crumbled just before the stock market's close.

…The result opens the door to debate around Moderna's entire pipeline, Foroohar said.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up